Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is an important complication in cancer patients taking intravenous BPs (BPs). In most cases, BRONJ is associated with an oral surgery procedure involving jaw bone. Currently, BRONJ management remains controversial, and there is no definitive standard of care for this disease. In fact, several articles in the recent literature discuss treatments that range from topical to surgical treatment, without definitive conclusion about treatment. A clinical study was conducted on 32 patients treated with i.v BPs for oncologic pathologies affected by BRONJ. The patients were treated by resection of the necrotic bone with primary closure of the mucosa over the bony defect using plasma rich in growth factors (PRGF). Orthopanoramic and computed tomography were performed before and after surgery. No intraoperative complications were observed, and all 32 cases were treated successfully. Our data on the use of PRGF demonstrate positive results for this surgical treatment. PRGF may enhance vascularization and regeneration of osseous and epithelial tissues.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.oraloncology.2011.12.004 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Local Single-Dose Teriparatide Administration for BRONJ Prevention: Insights from a Rat Model Study.
J Maxillofac Oral Surg
December 2024
Dental Implants Research Center, Dental Research Institute, School of Dentistry, Isfahan University of Medical Sciences, Hezar Jerib Avenue, Isfahan, Iran.
Background: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) presents significant clinical challenges with uncertain treatment outcomes. Teriparatide, a fragment of human parathyroid hormone, shows potential in prevention strategies for BRONJ.
Objective: This study investigates the impact of a single local dose of teriparatide on BRONJ prevention in an animal model.
AI in oral medicine: is the future already here? A literature review.
Br Dent J
November 2024
Clinical Lecturer in Oral Medicine, Division of Dentistry, School of Medical Sciences, FBMH, University of Manchester, UK.
Objective Artificial intelligence (AI) is reshaping many healthcare disciplines, mainly with newly developed computer systems or machines that have the ability to mimic human intelligence. This paper aims to review the available evidence on the applications of AI in oral medicine. The review critically assesses current evidence, shedding light on AI's growing role in this field.
View Article and Find Full Text PDFTargeting endoplasmic reticulum stress-induced lymphatic dysfunction for mitigating bisphosphonate-related osteonecrosis.
Clin Transl Med
November 2024
Department of Oral and Maxillofacial Surgery, The Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, China.
Background: Bisphosphonates (BPs) are the first-line treatment to stop bone resorption in diseases, including osteoporosis, Paget's disease, multiple myeloma and bone metastases of cancer. However, BPs-related osteonecrosis of the jaw (BRONJ), characterized by local inflammation and jawbone necrosis, is a severe intractable complication. The cumulative inflammatory burden often accompanies impaired lymphatic drainage, but its specific impact on BRONJ and the underlying mechanisms remain unclear.
View Article and Find Full Text PDFManagement of Medication-Related Osteonecrosis of the Jaws With Hyperbaric Oxygen Therapy: A Case Report.
Cureus
October 2024
Oral and Maxillofacial Surgery, Private Practice, New Delhi, IND.
Medication-related osteonecrosis of the jaw (MRONJ) refers to the condition where the maxillary or mandibular bone becomes exposed and necrotic as a result of bisphosphonate therapy. The number of patients on bisphosphonates is increasing and so are the MRONJ cases. Since the initial data were published in the early 2000s, research into MRONJ has expanded significantly to enhance the understanding of this emerging condition.
View Article and Find Full Text PDFInnovative Use of Limberg Flap for MRONJ Reconstruction.
J Craniofac Surg
November 2024
Department of Oral and Maxillofacial Surgery, Istanbul University, Fatih/İstanbul, Turkey.
Article Synopsis
- Medication-related osteonecrosis of the jaw (MRONJ) is a serious issue linked to bisphosphonate use, causing bone death in the jaw area.
- A 68-year-old woman with a cancer history faced complications after surgery for this condition, leading to the need for further reconstruction with a Limberg flap.
- The surgery successfully healed her condition and emphasizes the need for customized treatment approaches for MRONJ, showcasing the effective use of the Limberg flap in such cases.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!